Skip to main content

Jorge Hernández Vara

Institutions of which they are part

Main researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Jorge Hernández Vara

Institutions of which they are part

Main researcher
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Projects

Implicación del daño oxidativo en la fisiopatogenia de la ataxia de Friedreich y su relación con la progresión clínica de la enfermedad.

IP: Elena García Arumí
Collaborators: Jorge Hernández Vara, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 67390
Reference: PI030168
Duration: 01/01/2003 - 28/11/2006

Related news

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Related professionals

Hugo Fernando Avalos  Bogado

Hugo Fernando Avalos Bogado

Predoctoral researcher
Rheumatology
Read more
Elba Agusti Rovira

Elba Agusti Rovira

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Carlos Torrico Leon

Carlos Torrico Leon

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Elsa Ibarrola Carrasco

Elsa Ibarrola Carrasco

Research technician
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.